CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P. Patel, Patrizia Porazzi, Beatriz M. Carreno et al.|Science Immunology|2024Cited by 45
Clinical Development of <i>Senza5TM CART5:</i> a Novel Dual Population CD5 CRISPR-Cas9 Knocked out Anti-CD5 Chimeric Antigen Receptor T Cell Product for Relapsed and Refractory CD5+ Nodal T-Cell LymphomasRuchi P. Patel, Marco Ruella, Nicholas A. Siciliano et al.|Blood|2022Cited by 8